T1	Outcomes 83 95	brucellosis.
T2	Outcomes 146 188	efficacy, safety, and patient tolerability
T3	Outcomes 237 249	brucellosis:
T4	Outcomes 566 615	average number of days without fever and symptoms
T5	Outcomes 861 870	relapses;
T6	Outcomes 960 971	brucellosis
